Procter & Gamble Company (The) $PG Shares Acquired by AEGON ASSET MANAGEMENT UK Plc

AEGON ASSET MANAGEMENT UK Plc grew its holdings in Procter & Gamble Company (The) (NYSE:PG) by 21.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,303 shares of the company’s stock after acquiring an additional 228 shares during the period. AEGON ASSET MANAGEMENT UK Plc’s holdings in Procter & Gamble were worth $208,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of PG. Kingstone Capital Partners Texas LLC grew its stake in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Nuveen LLC acquired a new position in shares of Procter & Gamble in the first quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD grew its stake in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. grew its stake in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC grew its stake in shares of Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after acquiring an additional 1,674,139 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG opened at $147.45 on Thursday. Procter & Gamble Company has a 1-year low of $146.96 and a 1-year high of $180.43. The stock has a market cap of $345.11 billion, a PE ratio of 22.65, a price-to-earnings-growth ratio of 3.96 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The firm has a fifty day moving average price of $155.04 and a 200 day moving average price of $159.12.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same period in the previous year, the company earned $1.40 earnings per share. Procter & Gamble’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s payout ratio is 64.98%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on PG. BNP Paribas Exane decreased their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Wells Fargo & Company decreased their price objective on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. BNP Paribas reaffirmed an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research report on Friday, October 10th. Finally, Bank of America decreased their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $172.21.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the transaction, the chief executive officer directly owned 61,764 shares in the company, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 4,252 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the transaction, the chief financial officer owned 53,992 shares in the company, valued at approximately $8,219,202.16. This represents a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 over the last quarter. 0.20% of the stock is owned by corporate insiders.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.